Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1539833
Reference Type
Journal Article
Title
Susceptibility to cardiac ischemia/reperfusion injury modulated by an estrogen derivative
Author(s)
Figueroa-Valverde, L; Diaz-Cedillo, F; Garcia-Cervera, E; Pool-Gomez, E; Lopez-Ramos, M
Year
2012
Volume
6
Issue
33
Page Numbers
2493-2502
DOI
10.5897/AJPP12.293
Web of Science Id
WOS:000310808800009
Abstract
Several studies indicate that some steroid derivatives have
activity at cardiovascular level; nevertheless, there is scarce information about the effects of
the estradiol derivatives on cardiac injury ischemia/reperfusion (I/R). Therefore, in this study,
an estradiol derivative was synthetized with the objective of evaluating its activity on I/R in
an ischemia-reperfusion model. In addition, molecular mechanism involved in the activity of
effect induced by estradiol derivative on perfusion pressure and coronary resistance was
evaluated using the Langendorff technique by measuring left ventricular pressure in absence or
presence of the following compounds; tamoxifen, yohimbine, ICI 118,551 and L-NAME. The results
showed that estradiol derivative reduced infarct size compared with control. In addition, another
results showed that the estradiol derivative significantly decrease the perfusion pressure and
coronary resistance in isolated heart. Additionally, another data indicate that estradiol
derivative low left ventricular pressure in a dose-dependent manner (1 x 10(-9) to 1 x 10(-4)
mmol); however, this phenomenon was significantly inhibited by tamoxifen at a dose of 1 x 10(-6)
mmol and L-NAME (1 x 10(-6) mmol). In conclusion, these data suggest that cardioprotective effect
of estradiol derivative is through the interaction with estrogen receptor and activation of
nitric oxide synthase. This phenomenon results in decrease of myocardial necrosis after ischemia
and reperfusion.
Keywords
Estradiol derivative; ischemia/reperfusion; tamoxifen; L-NAME
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity